Exchange: NYSE·Updated 07:55 AM EDT
NUVB logo

NUVB Nuvation Bio Inc - Ordinary Shares - Class A

$6.70
$0.04
(0.60%)
Pre-Market
Prev Close $6.66
Reported EarningsAug 6
Mkt Cap$2.35B
Vol5,555.00

About NUVB

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.
29

Bearish Sentiment

How do you feel about NUVB?

Advertisement|Remove ads.